139 related articles for article (PubMed ID: 11028879)
21. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
[TBL] [Abstract][Full Text] [Related]
22. Fulminating Course of Drug Reaction with Eosinophilia and Systemic Symptoms exacerbated by a Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis overlap.
Har-Shai L; Savin Z; Canzoniero JV
Isr Med Assoc J; 2016 May; 18(5):304-5. PubMed ID: 27430091
[No Abstract] [Full Text] [Related]
23. Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature.
Kakar R; Paugh H; Jaworsky C
Dermatology; 2013; 227(3):209-13. PubMed ID: 24135381
[TBL] [Abstract][Full Text] [Related]
24. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
25. Drug-induced linear IgA bullous dermatosis mimicking toxic epidermal necrolysis.
Hughes AP; Callen JP
Dermatology; 2001; 202(2):138-9. PubMed ID: 11306837
[No Abstract] [Full Text] [Related]
26. An atypical presentation of pulmonary air-leak syndrome and multisystem toxic epidermal necrolysis.
Ellenburg JT; Josey D
Pediatr Pulmonol; 2014 Jun; 49(6):E130-4. PubMed ID: 24668933
[TBL] [Abstract][Full Text] [Related]
27. Etoricoxib-induced toxic epidermal necrolysis: A fatal case report.
Roy SS; Mukherjee S; Era N; Mukherjee M
Indian J Pharmacol; 2018; 50(3):139-142. PubMed ID: 30166751
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous adverse drug reactions: an 8-year retrospective study on hospitalized patients in Southern China.
Wang F; Li Y; Mo Y; Shen C; Yang L; Zhang X
Indian J Dermatol Venereol Leprol; 2012; 78(4):488-90. PubMed ID: 22772622
[No Abstract] [Full Text] [Related]
29. Dermatologic emergencies.
Usatine RP; Sandy N
Am Fam Physician; 2010 Oct; 82(7):773-80. PubMed ID: 20879700
[TBL] [Abstract][Full Text] [Related]
30. Drug-induced linear immunoglobulin A bullous disease that clinically mimics toxic epidermal necrolysis.
Mofid MZ; Costarangos C; Bernstein B; Wong L; Munster A; Nousari HC
J Burn Care Rehabil; 2000; 21(3):246-7. PubMed ID: 10850906
[TBL] [Abstract][Full Text] [Related]
31. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
[TBL] [Abstract][Full Text] [Related]
32. Fatal toxic epidermal necrolysis associated with hydroxychloroquine.
Murphy M; Carmichael AJ
Clin Exp Dermatol; 2001 Jul; 26(5):457-8. PubMed ID: 11488840
[No Abstract] [Full Text] [Related]
33. Ofloxacin eyedrops-induced toxic epidermal necrolysis treated with intravenous immunoglobulin.
Parmar NV; Kuruvila S; Ganguly S; Krishna CV
Int J Dermatol; 2014 Nov; 53(11):e547-8. PubMed ID: 25209837
[No Abstract] [Full Text] [Related]
34. Fatal toxic epidermal necrolysis associated with mefloquine antimalarial prophylaxis.
McBride SR; Lawrence CM; Pape SA; Reid CA
Lancet; 1997 Jan; 349(9045):101. PubMed ID: 8996426
[No Abstract] [Full Text] [Related]
35. Head and neck manifestations of erythema multiforme in children.
Stewart MG; Duncan NO; Franklin DJ; Friedman EM; Sulek M
Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 1):236-42. PubMed ID: 8084631
[TBL] [Abstract][Full Text] [Related]
36. [Toxic epidermal necrolysis due to anti-PD1 treatment with fatal outcome].
Demirtas S; El Aridi L; Acquitter M; Fleuret C; Plantin P
Ann Dermatol Venereol; 2017 Jan; 144(1):65-66. PubMed ID: 28011090
[No Abstract] [Full Text] [Related]
37. [Stevens-Jhonson syndrome associated with vancomcyn].
Santaeugenia S; Pedro Botet ML; Sabat M; Sopena N; Sadria M
Rev Esp Quimioter; 2000 Dec; 13(4):425-6. PubMed ID: 11498712
[No Abstract] [Full Text] [Related]
38. [Medications and Lyell syndrome].
Trottler C; Frenkel G
ZWR; 1991 Jan; 100(1):36-7. PubMed ID: 1882561
[TBL] [Abstract][Full Text] [Related]
39. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
Roujeau JC; Kelly JP; Naldi L; Rzany B; Stern RS; Anderson T; Auquier A; Bastuji-Garin S; Correia O; Locati F
N Engl J Med; 1995 Dec; 333(24):1600-7. PubMed ID: 7477195
[TBL] [Abstract][Full Text] [Related]
40. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
